USPTO Granted Patents = 49 (Patent Applications = 13)
CIPO Patents = 6 (Patent Applications = 4)
EPO Patents = 17 (Patent Applications = 15)
Average Co-Inventor Count = 4.3
ph-index = 17
Forward Citations = 696(Granted Patents)
Location History:
- Medway, MA (US) (2006 - 2010)
- San Diego, CA (US) (2007 - 2024)
Company Filing History:
Ambrx, Inc.
Enanta Pharmaceuticals, Inc.
Concortis Biosystems, Corp.
4. 2 out of 112
Sorrento Therapeutics, Inc.
5. 1 out of 1
Amerx, Inc.
6. 1 out of 1
Concortis Biosystems, Corp., a Wholly Owned Subsidiary of Sorrento Therapeutics, Inc.
7. 1 out of 26
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd.
8. 1 out of 10
Vivasor, Inc.
9. 1 out of 1
Abrx, Inc.
10. 1 out of 832,843 patents
Other
Years Active: 2006-2024
Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Drug-Conjugates
Antibody-Drug Conjugates
Non-Natural Amino Acids
Polypeptides
Hepatitis C Serine Protease Inhibitors
Modified Insulin Polypeptides
Targeting Molecules
Dolastatin Derivatives
Composition Methods
Conjugation Methods
Therapeutic Applications
Accelerants for Modification
49 patents (USPTO):Explore Patents
Hello! How can I assist you today?
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
13 patents pending:
Please report any incorrect information to support@idiyas.com
6 patents (CIPO):
Please report any incorrect information to support@idiyas.com
4 patents pending (CIPO):
Please report any incorrect information to support@idiyas.com
17 patents (EPO):
Please report any incorrect information to support@idiyas.com
15 patents pending (EPO):
Please report any incorrect information to support@idiyas.com